Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 14, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 October 2024 - 11:19

Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 14, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/suliqua

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters